Literature DB >> 11430885

Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain.

C Ibarra1, P I Nedvetsky, M Gerlach, P Riederer, H H Schmidt.   

Abstract

Nitric oxide (NO), synthesized by neuronal NO synthase (NOS-I), plays essential physiological roles in the brain. The major molecular target for NO is soluble guanylyl cyclase (sGC), a heterodimeric hemoprotein composed of a larger alpha and a smaller beta subunit. Both subunits of sGC are needed to generate the second messenger cyclic GMP (cGMP). Here we show using subunit-specific antibodies and Western blot analysis that sGCalpha1 and sGCbeta1 protein subunits are present in all examined human brain regions. The relative distribution of the two subunits was similar and also correlated well with the known distribution of NOS-I. The highest expression levels of sGC were found in cortex, basal ganglia and the limbic system. These regions display the most prominent biochemical and histological changes during ageing. In cortex, a negative correlation between the amounts of sGC and age was found, while sex and post-mortem delay time did not affect sGC levels significantly. Our data suggest that sGCalpha1 and sGCbeta1 subunits are widely distributed in human brain, consistent with a major role in NO signaling. Moreover, the NO/cGMP pathway appears to be affected by ageing in the human brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430885     DOI: 10.1016/s0006-8993(01)02588-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus.

Authors:  Alain Burette; Ulrike Zabel; Richard J Weinberg; Harald H H W Schmidt; Juli G Valtschanoff
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 2.  Regulation and function of cyclic GMP-mediated pathways in glial cells.

Authors:  María Antonia Baltrons; Mariela Susana Borán; Paula Pifarré; Agustina García
Journal:  Neurochem Res       Date:  2008-04-01       Impact factor: 3.996

3.  Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity.

Authors:  Iraida G Sharina; Filip Jelen; Elena P Bogatenkova; Anthony Thomas; Emil Martin; Ferid Murad
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

Review 4.  Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.

Authors:  Katarzyna Urszula Domek-Łopacińska; Joanna B Strosznajder
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

Review 5.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

6.  Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.

Authors:  Emil Martin; Eva Golunski; Susan T Laing; Anthony L Estrera; Iraida G Sharina
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-19       Impact factor: 4.733

Review 7.  The impact of age on vascular smooth muscle function in humans.

Authors:  David Montero; Gary L Pierce; Coen D A Stehouwer; Jaume Padilla; Dick H J Thijssen
Journal:  J Hypertens       Date:  2015-03       Impact factor: 4.844

Review 8.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

9.  Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells.

Authors:  Jenelle D Jones; Skyla T Carney; Kent E Vrana; Derek C Norford; Allyn C Howlett
Journal:  Neuropharmacology       Date:  2007-07-12       Impact factor: 5.250

10.  Soluble Guanylate Cyclase Stimulators and Activators.

Authors:  Peter Sandner; Daniel P Zimmer; G Todd Milne; Markus Follmann; Adrian Hobbs; Johannes-Peter Stasch
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.